Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Bunazosin is an antagonist of the α1-adrenergic receptor (α1-AR; Kd = 0.59 nM).1 It reduces glutamate-induced decreases in viability in primary rat retinal cells when used at concentrations of 1 and 10 µM.2 Ocular instillation of bunazosin (0.01%) prevents phenylephrine- or endothelin-1-induced constriction of retinal arteries in rabbits. It also prevents reductions in refractive error and increases in axial elongation in a mouse model of lens-induced myopia.3 Formulations containing bunazosin have been used in the treatment of glaucoma and ocular hypertension.
WARNING This product is not for human or veterinary use.
1. Characteristics of [3H]E-
2. Bunazosin, a selective α1-
3. Topical application of bunazosin hydrochloride suppresses myopia progression with an increase in choroidal blood perfusion. Invest. Ophthalmol. Vis. Sci. 64(14), 15 (2023).